Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 30,340 | 33,637 | 37,895 | 40,214 | 35,314 |
| Cost of Goods | 6,113 | 8,447 | 9,566 | 11,426 | 10,094 |
| Gross Profit | 24,227 | 25,190 | 28,329 | 28,788 | 25,220 |
| Operating Expenses | 36,518 | 39,640 | 39,569 | 37,843 | 34,540 |
| Operating Income | -12,178 | -14,003 | -10,674 | -8,629 | -9,226 |
| Interest Expense | 4 | 5 | 6 | 4 | 5 |
| Other Income | 2,376 | 2,254 | 2,508 | 2,707 | 2,906 |
| Pre-tax Income | -9,806 | -11,754 | -8,172 | -5,926 | -6,325 |
| Income Tax | 10 | 32 | 18 | 12 | 13 |
| Net Income Continuous | -9,816 | -11,786 | -8,190 | -5,938 | -6,338 |
| Net Income | $-9,816 | $-11,786 | $-8,190 | $-5,938 | $-6,338 |
| EPS Basic Total Ops | -0.24 | -0.29 | -0.20 | -0.14 | -0.16 |
| EPS Basic Continuous Ops | -0.24 | -0.29 | -0.20 | -0.14 | -0.16 |
| EPS Diluted Total Ops | -0.24 | -0.29 | -0.20 | -0.14 | -0.16 |
| EPS Diluted Continuous Ops | -0.24 | -0.29 | -0.20 | -0.14 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.24 | -0.29 | -0.20 | -0.15 | -0.16 |
| EBITDA(a) | $-13,468 | $-15,357 | $-12,300 | $-10,734 | $-10,856 |